AURA - CIK 0001501796
Aura Biosciences, Inc. trades as AURA. This page tracks Aura Biosciences, Inc. through 346 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-19 |
| Employee stock plan | S-8 | 2026-05-19 |
| SCHEDULE 13G | - | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-11 |
| Major company event | 8-K | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
| SCHEDULE 13D/A | - | 2026-05-11 |
| New insider ownership | 3 | 2026-05-07 |
The largest companies sharing Aura Biosciences, Inc.'s SEC industry classification (biological products, (no diagnostic substances)).
In its latest fiscal year Aura Biosciences, Inc. reported a net loss of $106.19M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.